tiprankstipranks
Trending News
More News >
BeiGene Ltd (HK:6160)
:6160
Hong Kong Market
Advertisement

BeiGene Ltd (6160) Similar Stocks

Compare
22 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
BeiGene Ltd
HK$201.00
HK$337.40B
38.91%
3 Buy
0 Hold
0 Sell
Strong Buy
Innovent Biologics
HK$95.10
$179.41B
128.03
98.21%
5 Buy
1 Hold
0 Sell
Strong Buy
Wuxi Biologics (Cayman)
HK$40.96
$171.69B
36.75
128.83%
8 Buy
2 Hold
0 Sell
Strong Buy
WuXi AppTec Co., Ltd. Class H
HK$119.40
HK$354.34B
23.58
117.80%
6 Buy
0 Hold
0 Sell
Strong Buy
Hansoh Pharmaceutical Group Company Limited
HK$37.02
HK$239.78B
45.62
75.37%
7 Buy
2 Hold
0 Sell
Strong Buy
Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class H
HK$87.80
HK$519.57B
78.29
4 Buy
1 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
HK:6160
BeiGene Ltd
201.00
62.70
45.34%
HK:1801
Innovent Biologics
93.95
47.75
103.35%
HK:2269
Wuxi Biologics (Cayman)
40.96
23.64
136.49%
HK:2359
WuXi AppTec Co., Ltd. Class H
119.40
67.12
128.39%
HK:3692
Hansoh Pharmaceutical Group Company Limited
37.02
16.50
80.41%
HK:1276
Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class H
87.80
34.10
63.50%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis